NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

BofA Upgrades Microchip to Buy, Sees More Upside Ahead

BofA analyst upgrades Microchip to Buy, raises price target to $95, citing inventory recovery, growth markets, and higher earnings forecasts.

BofA Upgrades Microchip to Buy, Sees More Upside Ahead
Credit: Caitlin O'Hara/Bloomberg
Already have an account? Sign in.
01/28/2026 · 6:37 AM
MCHP
/ Don’t stop at just one post.

Related↓

Microchip Technology Beats Expectations with Strong Q3 Sales Outlook
01/05/2026 · 5:00 PM

Microchip Technology Beats Expectations with Strong Q3 Sales Outlook

Microchip Technology raises Q3 fiscal 2026 sales forecast to $1.19B, beating estimates as semiconductor maker sees broad recovery across markets and strong bookings.

/ Subscriber only
/ Read more

Feed↓

Nike Shakes Up Innovation Team Again as Stock Hits 10-Year Low
04/10/2026 · 3:52 PM

Nike Shakes Up Innovation Team Again as Stock Hits 10-Year Low

Nike innovation chief leaves after less than a year amid falling sales, China struggles, and faster rivals; company reshuffles leadership.

/ Subscriber only
Commvault Explores Sale After Takeover Interest from Thoma Bravo
04/10/2026 · 1:23 PM

Commvault Explores Sale After Takeover Interest from Thoma Bravo

Commvault may be sold as buyers show interest. Stock down on AI fears but revenue growing; Thoma Bravo among potential bidders.

/ Subscriber only
FDA Rejects Replimune’s Skin Cancer Drug for the Second Time
Featured/ 04/10/2026 · 12:06 PM

FDA Rejects Replimune’s Skin Cancer Drug for the Second Time

FDA again rejects Replimune’s skin cancer drug RP1, saying studies don’t prove it works; shares halted, setback for company.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe